Home » Topics » Regulatory

Regulatory
RSS

Microsponge formulation of 5-FU approved by FDA for actinic keratoses

Oct. 31, 2000

Alza's Caelyx approved in E.U. for advanced ovarian cancer

Oct. 27, 2000

Unimed submits NDA for eprosartan/hydrochlorothiazide combination tablet

Oct. 27, 2000

Remicade recommended for approval in Europe for broader application

Oct. 26, 2000

First oral chemotherapy for colorectal cancer recommended for approval in Europe

Oct. 24, 2000

Once-weekly Fosamax approved by FDA

Oct. 24, 2000

Prilosec receives positive recommendation for OTC status

Oct. 24, 2000

SkyePharma's Solaraze earns FDA approval

Oct. 23, 2000

Meningococcal C meningitis vaccine approved for very young infants

Oct. 19, 2000

Dimethaid Research seeks approval for topical osteoarthritis treatment in Canada

Oct. 18, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...